• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
Entrada Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 1.614 M (forecast USD 8.621 M), actual EPS USD -1.0644 (forecast USD -0.99)
04:00
Entrada Therapeutics released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 24.12 M, actual EPS USD -2.5294
04:00
Aug7
Entrada Therapeutics released FY2025 Semi-Annual earnings on August 6 (EST), actual revenue USD 22.51 M, actual EPS USD -1.47
03:00
Entrada Therapeutics released FY2025 Q2 earnings on August 6 (EST), actual revenue USD 1.95 M (forecast USD 8.167 M), actual EPS USD -1.0426 (forecast USD -0.8475)
03:00
Jul11
5AM Ventures Reports Sale of Entrada Therapeutics Common Stock
21:26
Jun11
Entrada Therapeutics Held 2025 Annual Shareholders' Meeting
20:09

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.614 M, Net Income -44.13 M, EPS -1.0644

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.95 M, Net Income -43.1 M, EPS -1.0426

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 20.56 M, Net Income -17.35 M, EPS -0.4223

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
PCLA
0.3058
+148.42%
+0.182
HIHO
1.840
+121.69%
+1.000
ASPC
26.400
+112.22%
+13.960
AFJK
55.000
+71.82%
+22.990
TRIB
1.378
+54.45%
+0.488
ASTI
5.810
+49.74%
+1.930
POM
0.3787
+41.73%
+0.110
OPTX
2.688
+36.45%
+0.716
TIVC
2.332
+28.81%
+0.521
EUDA
1.730
+27.21%
+0.370
View More